Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infliximab for rheumatoid arthritis in a patient with tuberculosis.

× No keyword cloud information.

7 in total

Review 1. Risks and benefits of biologic therapy for inflammatory bowel diseases.

Authors: Geert D'Haens
Journal: Gut Date: 2007-05 Impact factor: 23.059

2. Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNFα therapy for Crohn's disease.

Authors: Caroline O'Dowd; Peter Kewin; John Morris; Mark Cotton
Journal: BMJ Case Rep Date: 2011-03-08

Review 3. Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors: Shunsuke Mori; Mineharu Sugimoto
Journal: Clin Rheumatol Date: 2011-12-15 Impact factor: 2.980

4. Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab.

Authors: Mehmet Unlu; Pınar Cimen; Aysu Ayranci; Tulay Akarca; Onur Karaman; Mustafa Sevket Dereli
Journal: Respir Med Case Rep Date: 2014-09-30

5. Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy.

Authors: Hironori Kawamoto; Jin Takasaki; Satoru Ishii; Manabu Suzuki; Eriko Morino; Go Naka; Motoyasu Iikura; Shinyu Izumi; Yuichiro Takeda; Haruhito Sugiyama
Journal: Respir Med Case Rep Date: 2017-04-15

6. Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.

Authors: Young Sun Suh; Seung-Ki Kwok; Ji Hyeon Ju; Kyung-Su Park; Sung-Hwan Park; Chong-Hyeon Yoon
Journal: J Korean Med Sci Date: 2013-12-26 Impact factor: 2.153

7. Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.

Authors: Takahiro Takazono; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Katsunori Yanagihara; Shigeru Kohno
Journal: BMC Infect Dis Date: 2014-02-28 Impact factor: 3.090

7 in total